The impact of preoperative anemia on oncologic outcome in patients undergoing radical cystectomy for urothelial carcinoma of the bladder.
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jo, Jung Ki | - |
dc.contributor.author | Jeong, Seong Jin | - |
dc.contributor.author | Hong, Sung Kyu | - |
dc.contributor.author | Byun, Seok-Soo | - |
dc.contributor.author | Lee, Sang Eun | - |
dc.contributor.author | Oh, Jong Jin | - |
dc.date.accessioned | 2022-07-15T17:48:31Z | - |
dc.date.available | 2022-07-15T17:48:31Z | - |
dc.date.created | 2021-05-14 | - |
dc.date.issued | 2016-04 | - |
dc.identifier.issn | 0301-1623 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/154787 | - |
dc.description.abstract | To investigate the impact of preoperative anemia (PA) on oncologic outcomes among patients who underwent radical cystectomy (RC) for bladder cancer. We reviewed the records of 200 patients undergoing RC between October 2003 and December 2014. Patients were categorized according to PA status. We performed multivariable Cox regression analyses to assess the impact of PA on oncological outcomes. Among 200 patients, 81 patients (40.5 %) had PA according to definition of the WHO classification. Fifty-two (26 %) of 200, 12 (6 %) of 200 and 61 (30.5 %) of 200 patients experienced the disease recurrence (DR), cancer-specific mortality (CSM) and all-cause mortality (ACM), respectively. In Kaplan-Meier analysis, the non-PA group showed a significantly higher 5-year DR-free survival than PA group (log-rank test: p = 0.018). The non-PA group showed a similar pattern of CSM and ACM (p = 0.004 and p = 0.037, respectively). In multivariable Cox proportional hazards analysis, PA was significantly associated with DR (HR 1.86, 95 % CI, p = 0.04) and ACM (HR 2.13, 95 % CI, p = 0.006) after adjusting other factors. The preoperative anemic bladder cancer patients who underwent RC had worse oncological outcomes than non-anemic bladder cancer patients. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | SPRINGER | - |
dc.title | The impact of preoperative anemia on oncologic outcome in patients undergoing radical cystectomy for urothelial carcinoma of the bladder. | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Jo, Jung Ki | - |
dc.identifier.doi | 10.1007/s11255-016-1219-x | - |
dc.identifier.scopusid | 2-s2.0-84961213613 | - |
dc.identifier.wosid | 000372588800006 | - |
dc.identifier.bibliographicCitation | INTERNATIONAL UROLOGY AND NEPHROLOGY, v.48, no.4, pp.489 - 494 | - |
dc.relation.isPartOf | INTERNATIONAL UROLOGY AND NEPHROLOGY | - |
dc.citation.title | INTERNATIONAL UROLOGY AND NEPHROLOGY | - |
dc.citation.volume | 48 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 489 | - |
dc.citation.endPage | 494 | - |
dc.type.rims | ART | - |
dc.type.docType | 정기학술지(Article(Perspective Article포함)) | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Urology & Nephrology | - |
dc.relation.journalWebOfScienceCategory | Urology & Nephrology | - |
dc.subject.keywordPlus | POSTOPERATIVE OUTCOMES | - |
dc.subject.keywordPlus | NONCARDIAC SURGERY | - |
dc.subject.keywordPlus | CANCER | - |
dc.subject.keywordPlus | RECURRENCE | - |
dc.subject.keywordPlus | MORTALITY | - |
dc.subject.keywordPlus | METAANALYSIS | - |
dc.subject.keywordPlus | MORBIDITY | - |
dc.subject.keywordAuthor | Urinary bladder neoplasms | - |
dc.subject.keywordAuthor | Cystectomy | - |
dc.subject.keywordAuthor | Anemia | - |
dc.subject.keywordAuthor | Prognosis | - |
dc.subject.keywordAuthor | Survival | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.